Exact Mass: 319.189582

Exact Mass Matches: 319.189582

Found 37 metabolites which its exact mass value is equals to given mass value 319.189582, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

Chloroquine

N(4)-(7-Chloro-4-quinolinyl)-N(1),N(1)-diethyl-1,4-pentanediamine

C18H26ClN3 (319.1815146)


Chloroquine is only found in individuals that have used or taken this drug. It is a prototypical antimalarial agent with a mechanism that is not well understood. It has also been used to treat rheumatoid arthritis, systemic lupus erythematosus, and in the systemic therapy of amebic liver abscesses. [PubChem]The mechanism of plasmodicidal action of chloroquine is not completely certain. Like other quinoline derivatives, it is thought to inhibit heme polymerase activity. This results in accumulation of free heme, which is toxic to the parasites. nside red blood cells, the malarial parasite must degrade hemoglobin to acquire essential amino acids, which the parasite requires to construct its own protein and for energy metabolism. Digestion is carried out in a vacuole of the parasite cell.During this process, the parasite produces the toxic and soluble molecule heme. The heme moiety consists of a porphyrin ring called Fe(II)-protoporphyrin IX (FP). To avoid destruction by this molecule, the parasite biocrystallizes heme to form hemozoin, a non-toxic molecule. Hemozoin collects in the digestive vacuole as insoluble crystals.Chloroquine enters the red blood cell, inhabiting parasite cell, and digestive vacuole by simple diffusion. Chloroquine then becomes protonated (to CQ2+), as the digestive vacuole is known to be acidic (pH 4.7); chloroquine then cannot leave by diffusion. Chloroquine caps hemozoin molecules to prevent further biocrystallization of heme, thus leading to heme buildup. Chloroquine binds to heme (or FP) to form what is known as the FP-Chloroquine complex; this complex is highly toxic to the cell and disrupts membrane function. Action of the toxic FP-Chloroquine and FP results in cell lysis and ultimately parasite cell autodigestion. In essence, the parasite cell drowns in its own metabolic products. P - Antiparasitic products, insecticides and repellents > P01 - Antiprotozoals > P01B - Antimalarials > P01BA - Aminoquinolines COVID info from Guide to PHARMACOLOGY, DrugBank, clinicaltrial, clinicaltrials, clinical trial, clinical trials D000890 - Anti-Infective Agents > D000977 - Antiparasitic Agents > D000981 - Antiprotozoal Agents C254 - Anti-Infective Agent > C276 - Antiparasitic Agent > C277 - Antiprotozoal Agent D018501 - Antirheumatic Agents Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS

   

JWH-251

2-(2-methylphenyl)-1-(1-pentyl-1H-indol-3-yl)-methanone

C22H25NO (319.193604)


   
   

(S)-2-[(2-Methyl-1-oxopropyl)amino]-N-(2-phenylethyl)pentanediamide

(S)-2-[(2-Methyl-1-oxopropyl)amino]-N-(2-phenylethyl)pentanediamide

C17H25N3O3 (319.189582)


   
   

Piroheptin-Metabolit*HBr

Piroheptin-Metabolit*HBr

C22H25NO (319.193604)


   
   
   

JWH 251 3-methylphenyl isomer

JWH 251 3-methylphenyl isomer

C22H25NO (319.193604)


   

chloroquine

chloroquine

C18H26ClN3 (319.1815146)


P - Antiparasitic products, insecticides and repellents > P01 - Antiprotozoals > P01B - Antimalarials > P01BA - Aminoquinolines COVID info from Guide to PHARMACOLOGY, DrugBank, clinicaltrial, clinicaltrials, clinical trial, clinical trials D000890 - Anti-Infective Agents > D000977 - Antiparasitic Agents > D000981 - Antiprotozoal Agents C254 - Anti-Infective Agent > C276 - Antiparasitic Agent > C277 - Antiprotozoal Agent D018501 - Antirheumatic Agents Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS

   

JWH 251 4-methylphenyl isomer

JWH 251 4-methylphenyl isomer

C22H25NO (319.193604)


   

butanedioic acid,1-(2-hydroxyethyl)-2,2,6,6-tetramethylpiperidin-4-ol

butanedioic acid,1-(2-hydroxyethyl)-2,2,6,6-tetramethylpiperidin-4-ol

C15H29NO6 (319.1994774)


   

(2-boc-aminophenyl)boronic acid, pinacol ester

(2-boc-aminophenyl)boronic acid, pinacol ester

C17H26BNO4 (319.1954786)


   

[1-(4-amino-benzoyl)-piperidin-4-yl]-carbamic acid tert-butyl ester

[1-(4-amino-benzoyl)-piperidin-4-yl]-carbamic acid tert-butyl ester

C17H25N3O3 (319.189582)


   

tert-Butyl 4-[(2-aminobenzene)amido]piperidine-1-carboxylate

tert-Butyl 4-[(2-aminobenzene)amido]piperidine-1-carboxylate

C17H25N3O3 (319.189582)


   

Carbamic acid, N-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]-, 1,1-dimethylethyl ester

Carbamic acid, N-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]-, 1,1-dimethylethyl ester

C17H26BNO4 (319.1954786)


   

1-(2-Ethylbutyl)-N-(2-sulfanylphenyl)cyclohexanecarboxamide

1-(2-Ethylbutyl)-N-(2-sulfanylphenyl)cyclohexanecarboxamide

C19H29NOS (319.19697440000004)


   

Amitriptyline-d6 hydrochloride

Amitriptyline-d6 hydrochloride

C20H18ClD6N (319.197380468)


   

4-(2-AMINO-PHENYLCARBAMOYL)-PIPERIDINE-1-CARBOXYLIC ACID TERT-BUTYL ESTER

4-(2-AMINO-PHENYLCARBAMOYL)-PIPERIDINE-1-CARBOXYLIC ACID TERT-BUTYL ESTER

C17H25N3O3 (319.189582)


   

tert-butyl 4-[(3-aminophenyl)carbamoyl]piperidine-1-carboxylate

tert-butyl 4-[(3-aminophenyl)carbamoyl]piperidine-1-carboxylate

C17H25N3O3 (319.189582)


   

4-(4-AMINO-PHENYLCARBAMOYL)-PIPERIDINE-1-CARBOXYLIC ACID TERT-BUTYL ESTER

4-(4-AMINO-PHENYLCARBAMOYL)-PIPERIDINE-1-CARBOXYLIC ACID TERT-BUTYL ESTER

C17H25N3O3 (319.189582)


   

[1-(3-AMINO-BENZOYL)-PIPERIDIN-4-YL]-CARBAMIC ACID TERT-BUTYL ESTER

[1-(3-AMINO-BENZOYL)-PIPERIDIN-4-YL]-CARBAMIC ACID TERT-BUTYL ESTER

C17H25N3O3 (319.189582)


   

Tert-butyl-n-[3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]carbamate

Tert-butyl-n-[3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]carbamate

C17H26BNO4 (319.1954786)


   
   
   
   

1,17-Dioxo-2,3-seco-androstan-3-oate

1,17-Dioxo-2,3-seco-androstan-3-oate

C19H27O4- (319.1909242)


   

Ethyl 4-(2-benzamidoethylamino)piperidine-1-carboxylate

Ethyl 4-(2-benzamidoethylamino)piperidine-1-carboxylate

C17H25N3O3 (319.189582)


   

N-[2-(1-cyclohexenyl)ethyl]-1-phenyl-4-pyrazolo[3,4-d]pyrimidinamine

N-[2-(1-cyclohexenyl)ethyl]-1-phenyl-4-pyrazolo[3,4-d]pyrimidinamine

C19H21N5 (319.1796866)


   

glycyl-L-leucyl-L-methioninamide cation

glycyl-L-leucyl-L-methioninamide cation

C13H27N4O3S+ (319.1803772)


   

(1S,9R,10R,11R)-10-(hydroxymethyl)-N,N-dimethyl-6-oxo-12-propyl-7,12-diazatricyclo[7.2.1.02,7]dodeca-2,4-diene-11-carboxamide

(1S,9R,10R,11R)-10-(hydroxymethyl)-N,N-dimethyl-6-oxo-12-propyl-7,12-diazatricyclo[7.2.1.02,7]dodeca-2,4-diene-11-carboxamide

C17H25N3O3 (319.189582)


   

(1R,9S,10S,11S)-10-(hydroxymethyl)-N,N-dimethyl-6-oxo-12-propyl-7,12-diazatricyclo[7.2.1.02,7]dodeca-2,4-diene-11-carboxamide

(1R,9S,10S,11S)-10-(hydroxymethyl)-N,N-dimethyl-6-oxo-12-propyl-7,12-diazatricyclo[7.2.1.02,7]dodeca-2,4-diene-11-carboxamide

C17H25N3O3 (319.189582)


   

(E)-1-(3,5-dimethylpiperidin-1-yl)-2,3-diphenylprop-2-en-1-one

(E)-1-(3,5-dimethylpiperidin-1-yl)-2,3-diphenylprop-2-en-1-one

C22H25NO (319.193604)


   
   

2-[(1-hydroxy-2-methylpropylidene)amino]-n-(2-phenylethyl)pentanediimidic acid

2-[(1-hydroxy-2-methylpropylidene)amino]-n-(2-phenylethyl)pentanediimidic acid

C17H25N3O3 (319.189582)


   
   

(2s)-2-[(1-hydroxy-2-methylpropylidene)amino]-n-(2-phenylethyl)pentanediimidic acid

(2s)-2-[(1-hydroxy-2-methylpropylidene)amino]-n-(2-phenylethyl)pentanediimidic acid

C17H25N3O3 (319.189582)